Avanos Medical Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Dave Pacitti
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | less than a year |
| CEO ownership | n/a |
| Management average tenure | 3.8yrs |
| Board average tenure | 10.6yrs |
Recent management updates
Recent updates
Avanos Medical: Cheap, But With Caveats
Apr 17Avanos Medical (NYSE:AVNS) Has A Pretty Healthy Balance Sheet
Apr 08
Lacklustre Performance Is Driving Avanos Medical, Inc.'s (NYSE:AVNS) Low P/S
Jan 30What Is Avanos Medical, Inc.'s (NYSE:AVNS) Share Price Doing?
Dec 18Avanos Medical, Inc.'s (NYSE:AVNS) Price Is Right But Growth Is Lacking
Oct 25There May Be Some Bright Spots In Avanos Medical's (NYSE:AVNS) Earnings
Aug 07Lacklustre Performance Is Driving Avanos Medical, Inc.'s (NYSE:AVNS) Low P/S
Apr 17Is Avanos Medical (NYSE:AVNS) A Risky Investment?
Jan 05Some Avanos Medical, Inc. (NYSE:AVNS) Analysts Just Made A Major Cut To Next Year's Estimates
Aug 14When Should You Buy Avanos Medical, Inc. (NYSE:AVNS)?
Aug 13Avanos Medical: Leaning Up, Attractive Returns On Incremental Capital, Reiterate Buy
Jul 16We Think Avanos Medical (NYSE:AVNS) Can Manage Its Debt With Ease
Jun 05Avanos Medical, Inc. (NYSE:AVNS) Stocks Pounded By 26% But Not Lagging Market On Growth Or Pricing
May 18Avanos Medical (NYSE:AVNS) Is Looking To Continue Growing Its Returns On Capital
May 07Is Avanos Medical (NYSE:AVNS) Using Too Much Debt?
Mar 02Avanos Medical Q4 2022 Earnings Preview
Feb 20Avanos Medical, Inc. (NYSE:AVNS) Shares Could Be 30% Below Their Intrinsic Value Estimate
Feb 10Why Avanos Medical, Inc. (NYSE:AVNS) Could Be Worth Watching
Jan 13Avanos Medical reports Q3 mixed earnings; reaffirms FY22 guidance
Nov 02Avanos: Recent Entry To Hyaluronic Acid Market Sparks Interesting Debate
Sep 12Avanos Medical Q2 2022 Earnings Preview
Aug 08CEO
Dave Pacitti (58 yo)
Mr. David C. Pacitti, MBA, also known as Dave, has been Chief Executive Officer of Avanos Medical Inc. since April 14, 2025. He served as Head of Americas at Siemens Healthineers AG since 2021 until April...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Senior Vice President of Operations | less than a year | US$977.39k | 0.095% $ 557.6k | |
| Senior VP | 3.8yrs | US$1.91m | 0.090% $ 528.0k | |
| Senior VP & Chief Commercial Officer | 6yrs | US$2.20m | 0.21% $ 1.2m | |
| Chief Executive Officer | less than a year | no data | no data | |
| Interim CFO | 4.3yrs | no data | 0.087% $ 507.0k | |
| VP & Chief Information Officer | no data | no data | no data | |
| VP and Chief Ethics & Compliance Officer | no data | no data | no data | |
| Vice President of Corporate Communications & Community Relations | no data | no data | no data | |
| Senior Vice President of Strategy & Corporate Development | no data | no data | no data | |
| Vice President of Global Human Resources | no data | no data | no data | |
| Senior Vice President of Global R&D | no data | no data | no data | |
| Senior Vice President of Quality | no data | no data | no data |
Experienced Management: AVNS's management team is considered experienced (3.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Independent Director | 10.6yrs | US$292.50k | 0.14% $ 842.4k | |
| Independent Chairman | 10.6yrs | US$396.88k | 0.15% $ 905.0k | |
| Independent Director | 2.2yrs | US$276.25k | 0.056% $ 326.3k | |
| Independent Director | 10.6yrs | US$291.25k | 0.13% $ 784.8k | |
| Independent Director | less than a year | US$140.00k | 0.036% $ 212.6k |
Experienced Board: AVNS's board of directors are seasoned and experienced ( 10.6 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/30 07:27 |
| End of Day Share Price | 2025/05/30 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Avanos Medical, Inc. is covered by 8 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Ravi Misra | Berenberg |
| Daniel Stauder | Citizens JMP Securities, LLC |
| Kristen Stewart | Deutsche Bank |